Effect of dipeptidyl peptidase-IV (DPP-IV) inhibitor (Vildagliptin) on peripheral nerves in streptozotocin-induced diabetic rats.
about
Incretin-Based Therapies for Diabetic Complications: Basic Mechanisms and Clinical EvidenceDiabetes resolution and hyperinsulinaemia after metabolic Roux-en-Y gastric bypass.Glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1: Incretin actions beyond the pancreas.Glucagon-like peptides 1 and 2 and vasoactive intestinal peptide are neuroprotective on cultured and mast cell co-cultured rat myenteric neuronsTreatment of streptozotocin-induced diabetic rats with alogliptin: effect on vascular and neural complications.Beneficial effects of exendin-4 on experimental polyneuropathy in diabetic mice.GLP-1 signals via ERK in peripheral nerve and prevents nerve dysfunction in diabetic miceNeuroprotective effect of the glucagon-like peptide-1 receptor agonist, synthetic exendin-4, in streptozotocin-induced diabetic ratsPhysiology of incretins in health and disease.Animal models as tools to investigate antidiabetic and anti-inflammatory plants.Protection of trigonelline on experimental diabetic peripheral neuropathy.Managing diabetic patients with moderate or severe renal impairment using DPP-4 inhibitors: focus on vildagliptinTherapeutic Potential of Dioscorea Extract (DA-9801) in Comparison with Alpha Lipoic Acid on the Peripheral Nerves in Experimental DiabetesNerve-Langerhans cell interactions in diabetes and agingEffect of granulocyte colony-stimulating factor on the peripheral nerves in streptozotocin-induced diabetic rat.The Aqueous Extract of Portulaca Oleracea Ameliorates Neurobehavioral Dysfunction and Hyperglycemia Related to Streptozotocin-Diabetes Induced in Ovariectomized Rats.Physiology of incretins and loss of incretin effect in type 2 diabetes and obesity.Early and late effects of the DPP-4 inhibitor vildagliptin in a rat model of post-myocardial infarction heart failure.DPP-4 inhibitors in diabetic complications: role of DPP-4 beyond glucose control.IRS proteins and diabetic complications.Incretin therapy for type 2 diabetes in Spain: a cost-effectiveness analysis of liraglutide versus sitagliptin.Effect of dipeptidyl peptidase-4 inhibition on circadian blood pressure during the development of salt-dependent hypertension in rats.Sensory and motor physiological functions are impaired in gastric inhibitory polypeptide receptor-deficient mice.The dipeptidyl peptidase-4 inhibitor sitagliptin protects against dyslipidemia-related kidney injury in Apolipoprotein E knockout miceRenoprotective Effects of the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin: A Review in Type 2 Diabetes.Characterisation of pain responses in the high fat diet/streptozotocin model of diabetes and the analgesic effects of antidiabetic treatments.Glucagon-like peptide 1, insulin, sensory neurons, and diabetic neuropathy.The dipeptidyl peptidase IV inhibitor vildagliptin suppresses development of neuropathy in diabetic rodents: Effects on peripheral sensory nerve function, structure and molecular changes.Chronic cyanidin-3-glucoside administration improves short-term spatial recognition memory but not passive avoidance learning and memory in streptozotocin-diabetic rats.Tackling dipeptidyl peptidase IV in neurological disorders.Anti-inflammatory effect of AMPK signaling pathway in rat model of diabetic neuropathy.The neuroprotective benefit from pioglitazone (PIO) addition on the alpha lipoic acid (ALA)-based treatment in experimental diabetic rats.
P2860
Q26739999-D351D97C-8CF0-42C0-854F-5F9FEC1AC591Q30394286-A08F00EE-4EF1-4F8A-ABDB-742871D89B58Q33603384-5D14C6AC-2018-4EE8-AD2A-C4F84DAA5960Q34215215-F8E882FF-A619-48F3-8B2E-886D0871D6E8Q35125198-D0614248-5E0A-47A2-A842-4FF36D9DB1B1Q35180081-96FBD014-BC88-4CF4-B6E7-D0603EEBD26AQ35226164-99F8863A-58D6-462C-A17A-AFB7B4C10C5AQ35564256-030760A6-DC08-4226-9F5E-47756389B832Q35760279-A86B64FF-EA5E-4AB3-9426-41CE29567E57Q36148540-41461535-D236-4D87-954C-F23F8780791FQ36477770-755A751A-CADD-4539-9B29-75CEBD1E73A2Q36805122-25A8A916-D166-400E-AD7F-81F0F9871F95Q36825657-44DFEBC8-B9C3-439D-9EC3-FF7F433C8ECEQ37022304-CC27DBFC-6EC1-4CEB-887A-E84C4A2D1820Q37121615-53F636D3-36C9-4731-8FAF-4B2FA6F241B6Q37246402-1CAF98D7-0443-4A0C-8CC2-AB7CFC0D55A5Q38122004-DAE11862-3D74-4B15-ABE0-3DCBFD712BA2Q38787227-F39F896C-11D1-4A70-B5DA-3E9525DD8B0BQ38922177-41ECFE10-FAB5-4FA5-B7B7-3764739A9F50Q38924963-EC002CFE-BBEA-483F-97F7-1DAA507980C7Q39331320-92233AC9-7FF9-465C-8F8C-1896E43CD34EQ39413684-140044F9-8CEB-41C9-8355-59B9ADE7B683Q39719357-C39C59B1-D654-474B-B34A-C37AAEF7E2E1Q41849344-D4E17EB1-CF2B-45E1-A9FB-E45863C9E0D9Q42876331-61020E74-8D78-44EA-B0C8-E40705C181FEQ43159888-95B5A267-BDDB-4510-ABE8-0B27059F39ABQ48511577-6F366052-BE8A-4A8E-8135-9962D88C2533Q48713671-E2C2A3CF-F1B2-4061-9DCF-89CC7A904722Q48722177-CFB9968D-3DE8-4A7B-B665-9F821CD5C259Q49940117-C360DC32-8034-4010-93E1-978DBB9E2F3AQ51582079-87E66A91-0A66-45C4-BB5A-6A039D8387A7Q53295371-F316C767-AE09-40B0-B1BC-903A1905C78F
P2860
Effect of dipeptidyl peptidase-IV (DPP-IV) inhibitor (Vildagliptin) on peripheral nerves in streptozotocin-induced diabetic rats.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Effect of dipeptidyl peptidase ...... zotocin-induced diabetic rats.
@en
Effect of dipeptidyl peptidase-IV
@nl
type
label
Effect of dipeptidyl peptidase ...... zotocin-induced diabetic rats.
@en
Effect of dipeptidyl peptidase-IV
@nl
prefLabel
Effect of dipeptidyl peptidase ...... zotocin-induced diabetic rats.
@en
Effect of dipeptidyl peptidase-IV
@nl
P2093
P1476
Effect of dipeptidyl peptidase ...... zotocin-induced diabetic rats.
@en
P2093
Heung Yong Jin
Hong Sun Baek
Ji Hyun Park
Tae Sun Park
Wei Jing Liu
P304
P356
10.1016/J.ARCMED.2009.09.005
P577
2009-10-01T00:00:00Z